polycitemia. Other diseases of blood and blood-forming organs
Conditions
Interventions
Intervention 1: Control group: phlebotomy only in the beginning of the study. Intervention 2: Intervention group: diet for 6 weeks in addition to phlebotomy at baseline. This diet is served as dinner
Treatment - Other
Control group: phlebotomy only in the beginning of the study
Intervention group: diet for 6 weeks in addition to phlebotomy at baseline. This diet is served as dinner and until two hours after, is no longer used for food. One's daily consumption is determined b
Sponsors
Research and Technology Vice-Chancellory of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
35 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: male patients; polycythemia without underlying disease; age range 35-60 years; no medication two weeks before entering the study Exclusion criteria: food allergy; history of the underlying disease; history of experience disease; history of drug use before entering the study; Smoking a cigarette, tobacco and narcotics; lack of consent to continue the project; the possible incidence of side effects
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood fluidity. Timepoint: Baseline, the end of the study. Method of measurement: R/S-CC Plus Coaxial Cylinder Rheometer Brookfield-type. | — |
Secondary
| Measure | Time frame |
|---|---|
| CBC. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.;Lipid profile. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.;Plasma fibrinogen. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.;Plasma osmolality. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.;FBS. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed